Browse grants
Federal and state grant opportunities with plain-English eligibility summaries. We aggregate public records — always verify the details on the funder’s site before applying. Or browse the complete index →
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)
Due May 8, 2027National Institutes of Health · Amount varies
This NIH mentored career development award (K08) prepares individuals with a clinical doctoral degree for research careers through supervised biomedical, behavioral, or translational research, and this version requires an independent clinical trial. It is intended for individual clinician-investigators applying through eligible institutions such as universities and academic medical centers. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityEnhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
Due Jun 2, 2027National Institutes of Health · Amount varies
This NIH (R61/R33) phased opportunity funds mechanistic research to advance precision probiotic therapies, beginning with an exploratory phase to identify person-specific factors and a second phase to test them in animal models or human subjects, over a combined period of up to five years. Eligible applicants are U.S. research organizations including universities, government and tribal entities, and faith- or community-based organizations; foreign organizations and non-U.S. components are not eligible to apply, though some foreign components are allowed. Transition between phases depends on meeting milestones. It is intended for established research teams, not individuals or general nonprofits. Award amounts are not specified.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityEnhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
Due Jun 2, 2027National Institutes of Health · Amount varies
This NIH (R33) opportunity funds mechanistic research to advance precision probiotic therapies by characterizing person-specific factors that affect probiotic responses, using animal models or human subjects. Eligible applicants are U.S. research organizations including universities, government and tribal entities, and faith- or community-based organizations; foreign organizations and non-U.S. components are not eligible to apply, though some foreign components are allowed. It expects supportive preliminary data and is intended for established research teams, not individuals or general nonprofits. Award amounts are not specified.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityBRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)
Due Jun 15, 2027National Institutes of Health · Amount varies
This NIH BRAIN Initiative (U24) program funds establishment of facilities at minority-serving institutions and IDeA-eligible institutions to produce and distribute brain cell type-specific research reagents to the neuroscience community. Eligibility is narrowed to minority-serving and IDeA-eligible U.S. institutions; foreign organizations and non-U.S. components are not eligible to apply, though some foreign components are allowed. It is intended for qualifying research institutions, not individuals or general nonprofits, and awardees must coordinate with existing Armamentarium project teams. Award amounts are not specified.
ResearchersSchools & universitiesNarrow eligibilityChange of Recipient Organization (Type 7 Parent Clinical Trial Optional)
Due Jul 12, 2027National Institutes of Health · Amount varies
This NIH mechanism is narrowly limited to organizations that already hold specific types of NIH grants and need to transfer an existing award to a new recipient institution (a change of recipient organization). It is an administrative prior-approval request, not a new funding opportunity, and there is no guarantee a transfer will be approved. Only current NIH grantee organizations should apply; it does not apply to individuals, new applicants, or general nonprofits. No award amount applies.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilitySuccessor-in-Interest (Type 6 Parent Clinical Trial Optional)
Due Jul 17, 2027National Institutes of Health · Amount varies
This NIH mechanism is narrowly limited to organizations that already hold specific NIH grants and need to transfer an award due to a change in organizational status (successor-in-interest). It is an administrative prior-approval request, not a new funding opportunity, and approval of the transfer is not guaranteed. Only current NIH grantee organizations should use it; it does not apply to individuals, new applicants, or general nonprofits. No award amount applies.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityCutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
Due Aug 11, 2027National Institutes of Health · Up to $150K
The NIDA Cutting-Edge Basic Research Award (CEBRA) funds highly innovative, high-risk basic research into substance use disorders that falls outside NIDA's typical portfolio. Eligible applicants include universities, minority- and tribal-serving institutions, and similar research organizations. Awards go up to $150,000.
ResearchersBroad eligibilityBlueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Due Aug 18, 2027National Institutes of Health · Amount varies
This NIH program supports preclinical discovery and development of biologic-based therapies for nervous system disorders, from lead optimization through Phase I clinical testing. Eligible applicants are research organizations such as universities, colleges, government and tribal agencies, faith- or community-based organizations, and (for this announcement) foreign organizations; it is geared toward established research teams, not individuals or general nonprofits. Award amounts are not specified. Applicants should be prepared for a complex, multi-phase research undertaking with NIH-funded consultants and contract research organizations.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityInvestigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
Due Sep 7, 2027National Institutes of Health · Amount varies
This NIH (R21) opportunity supports exploratory research in computational genomics, data science, statistics, and bioinformatics relevant to basic or clinical genomic science and human health. Eligible applicants are research organizations including universities, colleges, government and tribal entities, and faith- or community-based organizations; it is intended for established research teams rather than individuals or general nonprofits. Award amounts are not specified. Methods should be generalizable and scalable to large datasets.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityInvestigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
Due Sep 7, 2027National Institutes of Health · Amount varies
This NIH (R01) opportunity funds research in computational genomics, data science, statistics, and bioinformatics relevant to basic or clinical genomic science and broadly applicable to human health. Eligible applicants are research organizations including universities, colleges, government and tribal entities, and faith- or community-based organizations; it targets established research teams rather than individuals or general nonprofits. Award amounts are not specified. Methods are expected to be generalizable and scalable to large datasets.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityBioengineering Partnerships with Industry (U01 Clinical Trial Optional)
Due Sep 7, 2027National Institutes of Health · Amount varies
This NIH (U01) program funds academic-industry research partnerships that develop and advance bioengineering tools and technologies to address biomedical problems, aiming for solutions deployable within roughly 5-10 years. Eligible applicants are research organizations including universities, colleges, government and tribal entities, and faith- or community-based organizations; it is geared toward multidisciplinary research teams partnered with industry, not individuals or general nonprofits. Award amounts are not specified. Applicants should expect a collaborative, milestone-driven structure.
ResearchersSchools & universitiesSmall businessGovernment / tribal+1 moreInterventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
Due Sep 7, 2027National Institutes of Health · Amount varies
This NIH (R01) opportunity funds non-pharmacological interventions to promote sleep health and reduce sleep-related health disparities among populations that experience health disparities. Eligible applicants are U.S. research organizations including universities, government and tribal entities, and faith- or community-based organizations; foreign organizations and non-U.S. components are not eligible to apply. It is intended for established research teams, not individuals or general nonprofits. Award amounts are not specified.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityNIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
Due Sep 7, 2027National Institutes of Health · Amount varies
This NIH (R13) program supports conferences and scientific meetings relevant to public health and the missions of participating NIH institutes. Eligible applicants are U.S. research and education organizations including universities, government and tribal entities, and faith- or community-based organizations; foreign organizations and non-U.S. components are not eligible to apply, though some foreign components are allowed. Note that R13 conference support typically requires advance permission from the funding institute before applying. It is aimed at organizations hosting scientific conferences, not individuals. Award amounts are not specified.
ResearchersSchools & universitiesNonprofitsGovernment / tribal+1 moreD-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
Due Sep 7, 2027National Institutes of Health · Up to $100K
This NIH (NIDA, R03) award helps investigators enter addiction-related data science, supporting small-scale projects that apply emerging data science methods or generate preliminary data for larger studies, with a budget cap around $100,000. Eligible applicants are research organizations including universities, colleges, government and tribal entities, and faith- or community-based organizations; it is intended for investigators at research institutions, not individuals or general nonprofits. It encourages use of existing datasets and FAIR principles. Confirm program-specific eligibility in the full announcement.
ResearchersSchools & universitiesGovernment / tribalSmall award+1 moreIntegrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
Due Sep 10, 2027National Institutes of Health · Amount varies
This NIH (NCI, U01) program funds research on how preanalytical variability in handling tumor tissue, blood, and other biospecimens affects clinically relevant biomarkers, to support standardization of biopsy handling and clinical assay development. Eligible applicants are research organizations including universities, colleges, government and tribal entities, and faith- or community-based organizations; it targets established research teams, not individuals or general nonprofits. Award amounts are not specified. Confirm program-specific eligibility in the full announcement.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityUtilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
Due Oct 8, 2027National Institutes of Health · Amount varies
This NIH/NCI U01 funds cancer etiology and early-detection biomarker research that must use the NCI-sponsored PLCO Screening Trial biospecimen resource. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, tribal governments, foreign organizations, and U.S. territories; it targets research organizations, not individuals. No award amount is specified. Projects that do not use PLCO biospecimens will not be funded, which narrows eligibility significantly.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreNCI Pathway to Independence Award (K99/R00 Clinical Trial Required)
Due Oct 14, 2027National Institutes of Health · Amount varies
This NIH/NCI K99/R00 career award supports postdoctoral cancer researchers transitioning to independent faculty positions, with a clinical trial required. It is applied for through a host research or education institution but effectively targets individual early-career investigators; foreign organizations are not eligible. No award amount is specified. Applicants should confirm they meet the career-stage and eligibility criteria, which are specific.
ResearchersSchools & universitiesIndividualsNarrow eligibilityNCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
Due Oct 14, 2027National Institutes of Health · Amount varies
This NIH/NCI K99/R00 career award supports postdoctoral cancer researchers transitioning to independent faculty positions, providing mentored and then independent research funding. It is applied for through a host research or education institution, but it effectively targets individual early-career investigators who meet eligibility requirements; foreign organizations are not eligible. No award amount is specified. Applicants should confirm they meet the career-stage and eligibility criteria, which are specific.
ResearchersSchools & universitiesIndividualsNarrow eligibilityCancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
Due Oct 25, 2027National Institutes of Health · Amount varies
This NIH/NCI R34 planning grant funds the design and preparation of cancer prevention and control clinical trials, covering screening, early detection, supportive care, and survivorship. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, tribal governments, foreign organizations, and U.S. territories; it targets research organizations, not individuals. No award amount is specified. It funds trial-planning activities rather than the trials themselves.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreCancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
Due Oct 25, 2027National Institutes of Health · Amount varies
This NIH/NCI U34 planning grant funds the design and preparation of cancer prevention and control clinical trials, including studies on screening, early detection, and survivorship. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, tribal governments, foreign organizations, and U.S. territories; it is aimed at research organizations, not individuals. No award amount is specified. It funds trial-planning work rather than the trials themselves, so review the scope carefully.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 more